Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2542 | 3755 | 47.3 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
27 | 3 | DEVELOPMENTAL BIOLOGY//DEVELOPMENT//AGR2 | 109777 |
2542 | 2 | CADASIL//NOTCH3//NOTCH | 3755 |
3243 | 1 | NOTCH1//NOTCH//GAMMA SECRETASE INHIBITOR | 2030 |
11708 | 1 | DLL4//VASC PATTERNING//DELTA LIKE LIGAND 4 | 960 |
14523 | 1 | CADASIL//NOTCH3//NOTCH3 GENE | 765 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CADASIL | authKW | 2755514 | 11% | 85% | 397 |
2 | NOTCH3 | authKW | 1214880 | 5% | 80% | 187 |
3 | NOTCH | authKW | 770487 | 14% | 18% | 539 |
4 | NOTCH1 | authKW | 738425 | 7% | 37% | 246 |
5 | NOTCH SIGNALING | authKW | 352355 | 5% | 24% | 180 |
6 | GAMMA SECRETASE INHIBITOR | authKW | 308523 | 2% | 43% | 88 |
7 | NOTCH3 GENE | authKW | 300812 | 1% | 100% | 37 |
8 | DLL4 | authKW | 256735 | 1% | 69% | 46 |
9 | JAGGED1 | authKW | 202567 | 2% | 36% | 69 |
10 | NOTCH SIGNALING PATHWAY | authKW | 131360 | 1% | 39% | 41 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7910 | 25% | 0% | 938 |
2 | Cell Biology | 5321 | 21% | 0% | 773 |
3 | Developmental Biology | 5098 | 8% | 0% | 290 |
4 | Hematology | 3296 | 10% | 0% | 365 |
5 | Clinical Neurology | 2990 | 14% | 0% | 509 |
6 | Peripheral Vascular Diseases | 1481 | 7% | 0% | 245 |
7 | Pathology | 1073 | 5% | 0% | 204 |
8 | Medicine, Research & Experimental | 761 | 6% | 0% | 242 |
9 | Immunology | 753 | 9% | 0% | 322 |
10 | Cell & Tissue Engineering | 542 | 1% | 0% | 45 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VASC PATTERNING | 126921 | 1% | 71% | 22 |
2 | U740 | 90316 | 1% | 56% | 20 |
3 | MED GENET DEV BIOL | 67091 | 1% | 26% | 32 |
4 | UMRS 1161 | 48780 | 0% | 100% | 6 |
5 | TISSUE MORPHOGENESIS | 37708 | 1% | 22% | 21 |
6 | GENET PATHOGENESIS CEREBROVASC DIS | 32520 | 0% | 100% | 4 |
7 | ACCELERATED VASC | 32512 | 0% | 50% | 8 |
8 | E365 | 25403 | 0% | 63% | 5 |
9 | D38 | 24390 | 0% | 100% | 3 |
10 | STROKE DEMENTIA | 22892 | 1% | 10% | 29 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BLOOD | 3006 | 3% | 0% | 116 |
2 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 2719 | 0% | 3% | 11 |
3 | DEVELOPMENTAL CELL | 2257 | 1% | 1% | 27 |
4 | STROKE | 2225 | 2% | 0% | 64 |
5 | IMMUNITY | 2082 | 1% | 1% | 30 |
6 | DEVELOPMENT | 1849 | 1% | 0% | 55 |
7 | ONCOTARGET | 1444 | 1% | 0% | 48 |
8 | CANCER CELL | 1332 | 0% | 1% | 16 |
9 | CANCER RESEARCH | 1332 | 2% | 0% | 84 |
10 | CIRCULATION RESEARCH | 1219 | 1% | 0% | 40 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CADASIL | 2755514 | 11% | 85% | 397 | Search CADASIL | Search CADASIL |
2 | NOTCH3 | 1214880 | 5% | 80% | 187 | Search NOTCH3 | Search NOTCH3 |
3 | NOTCH | 770487 | 14% | 18% | 539 | Search NOTCH | Search NOTCH |
4 | NOTCH1 | 738425 | 7% | 37% | 246 | Search NOTCH1 | Search NOTCH1 |
5 | NOTCH SIGNALING | 352355 | 5% | 24% | 180 | Search NOTCH+SIGNALING | Search NOTCH+SIGNALING |
6 | GAMMA SECRETASE INHIBITOR | 308523 | 2% | 43% | 88 | Search GAMMA+SECRETASE+INHIBITOR | Search GAMMA+SECRETASE+INHIBITOR |
7 | NOTCH3 GENE | 300812 | 1% | 100% | 37 | Search NOTCH3+GENE | Search NOTCH3+GENE |
8 | DLL4 | 256735 | 1% | 69% | 46 | Search DLL4 | Search DLL4 |
9 | JAGGED1 | 202567 | 2% | 36% | 69 | Search JAGGED1 | Search JAGGED1 |
10 | NOTCH SIGNALING PATHWAY | 131360 | 1% | 39% | 41 | Search NOTCH+SIGNALING+PATHWAY | Search NOTCH+SIGNALING+PATHWAY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHABRIAT, H , JOUTEL, A , DICHGANS, M , TOURNIER-LASSERVE, E , BOUSSER, MG , (2009) CADASIL.LANCET NEUROLOGY. VOL. 8. ISSUE 7. P. 643-653 | 104 | 91% | 237 |
2 | LEONG, KG , KARSAN, A , (2006) RECENT INSIGHTS INTO THE ROLE OF NOTCH SIGNALING IN TUMORIGENESIS.BLOOD. VOL. 107. ISSUE 6. P. 2223-2233 | 109 | 78% | 296 |
3 | ANDRE, C , (2010) CADASIL PATHOGENESIS, CLINICAL AND RADIOLOGICAL FINDINGS AND TREATMENT.ARQUIVOS DE NEURO-PSIQUIATRIA. VOL. 68. ISSUE 2. P. 287-299 | 114 | 92% | 18 |
4 | TIKKA, S , BAUMANN, M , SIITONEN, M , PASANEN, P , POYHONEN, M , MYLLYKANGAS, L , VIITANEN, M , FUKUTAKE, T , COGNAT, E , JOUTEL, A , ET AL (2014) CADASIL AND CARASIL.BRAIN PATHOLOGY. VOL. 24. ISSUE 5. P. 525 -544 | 97 | 86% | 13 |
5 | GRIDLEY, T , (2010) NOTCH SIGNALING IN THE VASCULATURE.NOTCH SIGNALING. VOL. 92. ISSUE . P. 277-309 | 103 | 77% | 98 |
6 | NTZIACHRISTOS, P , LIM, JS , SAGE, J , AIFANTIS, I , (2014) FROM FLY WINGS TO TARGETED CANCER THERAPIES: A CENTENNIAL FOR NOTCH SIGNALING.CANCER CELL. VOL. 25. ISSUE 3. P. 318 -334 | 106 | 49% | 83 |
7 | YAMAMOTO, Y , CRAGGS, L , BAUMANN, M , KALIMO, H , KALARIA, RN , (2011) MOLECULAR GENETICS AND PATHOLOGY OF HEREDITARY SMALL VESSEL DISEASES OF THE BRAIN.NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. VOL. 37. ISSUE 1. P. 94-113 | 109 | 72% | 35 |
8 | RUTTEN, JW , HAAN, J , TERWINDT, GM , VAN DUINEN, SG , BOON, EMJ , OBERSTEIN, SAJL , (2014) INTERPRETATION OF NOTCH3 MUTATIONS IN THE DIAGNOSIS OF CADASIL.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 14. ISSUE 5. P. 593-603 | 78 | 96% | 11 |
9 | ESPINOZA, I , MIELE, L , (2013) NOTCH INHIBITORS FOR CANCER TREATMENT.PHARMACOLOGY & THERAPEUTICS. VOL. 139. ISSUE 2. P. 95-110 | 121 | 48% | 63 |
10 | HERVE, D , CHABRIAT, H , (2010) CADASIL.JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. VOL. 23. ISSUE 4. P. 269-276 | 82 | 93% | 28 |
Classes with closest relation at Level 2 |